Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 17 drugs
| No. | KEGG DRUG | DrugBank | Drug (Description in trials) | KEGG GENES | KEGG PATHWAY | Disease ID | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
Hydrocortisone
1. Hydrocortisone
| [1] Hydrocortisone Hydrocortisone | [6] Cortef Cortef; Cortisol; Cortisone; Hydrocortisone; Hydrocortisone cream; Hydrocortisonum | [1] NR3C1 NR3C1 💬1. Hydrocortisone
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [10] 6 6, 41, 46, 53, 75, 78, 81, 83, 97, 299 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 |
Corticotropin
2. Corticotropin
| [1] Corticotropin Corticotropin | [5] ACTH ACTH; Acthar; Adrenocorticotropic hormone; Corticotrophin; Corticotropin | [1] MC2R MC2R 💬2. Corticotropin
| [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroac ... | [12] 2 2, 13, 14, 46, 49, 50, 66, 75, 81, 84, 145, 222 💬2. Corticotropin
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 |
Dexamethasone
3. Dexamethasone
| [1] Dexamethasone Dexamethasone | [5] Decadron Decadron; Dexametasona; Dexamethasone; DEXAMETHASONE SODIUM PHOSPHATE; Maxidex | [1] NR3C1 NR3C1 💬3. Dexamethasone
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [22] 13 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299 💬 [22] 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299💬 ... 3. Dexamethasone
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 |
Nifedipine
4. Nifedipine
| [1] Nifedipine Nifedipine | [1] Nifedipine Nifedipine | [4] CACNA1C CACNA1C,CACNA1D, CACNA1F, CACNA1S 💬 | [37] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 [37] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, ... | [2] 50 50, 81 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 |
Prednisolone
5. Prednisolone
| [1] Prednisolone Prednisolone | [3] Prednisolona Prednisolona; PREDNISOLONE; Prednisolonum | [1] NR3C1 NR3C1 💬5. Prednisolone
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [42] 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 [42] 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, ... 5. Prednisolone
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 |
Prednisone
6. Prednisone
| [1] Prednisone Prednisone | [3] PREDNISONA PREDNISONA; Prednisone; RAYOS | [1] NR3C1 NR3C1 💬6. Prednisone
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [45] 2 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331 💬 [45] 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, ... 6. Prednisone
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 |
Flutamide
7. Flutamide
| [1] Flutamide Flutamide | [1] Flutamide Flutamide | [1] AR AR 💬7. Flutamide
| [4] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 [4] Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate canc ... | [1] 81 81 💬7. Flutamide
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 |
Letrozole
8. Letrozole
| [1] Letrozole Letrozole | [1] Letrozole Letrozole | [1] CYP19A1 CYP19A1 💬8. Letrozole
| [3] Metabolic pathways Metabolic pathways, Ovarian steroidogenesis, Steroid hormone biosynthesis 💬 | [2] 81 81, 89 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 |
Cortisone acetate
9. Cortisone acetate
| [1] Cortisone acetate Cortisone acetate | [1] Cortisone acetate Cortisone acetate | [1] NR3C1 NR3C1 💬9. Cortisone acetate
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 💬9. Cortisone acetate
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 |
Hydrocortisone cypionate
10. Hydrocortisone cypionate
| [1] Hydrocortisone cypionate Hydrocortisone cypionate | [1] Cortef Cortef | [1] NR3C1 NR3C1 💬10. Hydrocortisone cypionate
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 6 6, 81, 83 💬
|